OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2023
(2)
2022
(2)
2020
(2)
2025
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.
Not available
S-EPMC9031205
|
biostudies-literature
Cite
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-
versus
-host disease prediction after unrelated donor hematopoietic cell transplantation.
Not available
S-EPMC7109721
|
biostudies-literature
Cite
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.
Not available
S-EPMC6086331
|
biostudies-literature
Cite
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia.
Not available
S-EPMC7543560
|
biostudies-literature
Cite
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Not available
S-EPMC9949804
|
biostudies-literature
Cite
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Not available
S-EPMC9200637
|
biostudies-literature
Cite
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial.
Not available
S-EPMC12018986
|
biostudies-literature
Cite
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Not available
S-EPMC9911671
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets